TG Therapeutics Inc
NASDAQ:TGTX

Watchlist Manager
TG Therapeutics Inc Logo
TG Therapeutics Inc
NASDAQ:TGTX
Watchlist
Price: 30.76 USD -1.98% Market Closed
Market Cap: 4.9B USD

Relative Value

The Relative Value of one TGTX stock under the Base Case scenario is hidden USD. Compared to the current market price of 30.76 USD, TG Therapeutics Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TGTX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
87
vs Industry
31
Median 3Y
13.4
Median 5Y
95.3
Industry
7.9
Forward
7.7
vs History
33
vs Industry
0
Median 3Y
12.1
Median 5Y
-4.8
Industry
24
Forward
10.3
vs History
vs Industry
Median 3Y
-49.8
Median 5Y
-20.9
Industry
21.6
vs History
vs Industry
2
Median 3Y
-15.2
Median 5Y
-16
Industry
23.7
vs History
85
vs Industry
2
Median 3Y
20
Median 5Y
15.5
Industry
3.4
vs History
87
vs Industry
26
Median 3Y
13.1
Median 5Y
77.1
Industry
8.3
Forward
7.9
vs History
77
vs Industry
23
Median 3Y
14.8
Median 5Y
21.2
Industry
10.3
vs History
26
vs Industry
1
Median 3Y
34.5
Median 5Y
-4.2
Industry
6.7
Forward
34.6
vs History
26
vs Industry
0
Median 3Y
34.6
Median 5Y
-4.2
Industry
7.2
Forward
36.1
vs History
vs Industry
Median 3Y
-46.7
Median 5Y
-18.6
Industry
8.2
vs History
vs Industry
Median 3Y
-46.7
Median 5Y
-18.6
Industry
6.7
vs History
76
vs Industry
8
Median 3Y
28.5
Median 5Y
28.5
Industry
5.7

Multiples Across Competitors

TGTX Competitors Multiples
TG Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
TG Therapeutics Inc
NASDAQ:TGTX
4.8B USD 9 10.7 47.5 47.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 071 784.8 -161 938.1 -196 644.6 -194 400.6
US
Abbvie Inc
NYSE:ABBV
399.6B USD 6.7 170.2 16.5 23.4
US
Amgen Inc
NASDAQ:AMGN
177.5B USD 4.9 25.3 18.3 18.3
US
Gilead Sciences Inc
NASDAQ:GILD
150.6B USD 5.2 18.6 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.7B USD 9.9 31.5 23.1 24.1
US
Epizyme Inc
F:EPE
94.1B EUR 2 067.7 -527.6 -574.5 -559.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
75.6B USD 5.3 16.5 15.7 17.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
60.4B USD 18.8 1 385.9 182.8 221.7
AU
CSL Ltd
ASX:CSL
89.9B AUD 3.8 19.9 13.3 16.6
NL
argenx SE
XBRU:ARGX
47.2B EUR 15.2 35.8 62 63.7
P/E Multiple
Earnings Growth PEG
US
TG Therapeutics Inc
NASDAQ:TGTX
Average P/E: 190.5
10.7
153%
0.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 938.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
170.2
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.3
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.6
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.5
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.5
9%
1.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 385.9
N/A N/A
AU
CSL Ltd
ASX:CSL
19.9
11%
1.8
NL
argenx SE
XBRU:ARGX
35.8
40%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
TG Therapeutics Inc
NASDAQ:TGTX
Average EV/EBITDA: 43.5
47.5
121%
0.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 644.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.5
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.3
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.1
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -574.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
182.8
N/A N/A
AU
CSL Ltd
ASX:CSL
13.3
8%
1.7
NL
argenx SE
XBRU:ARGX
62
807%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
TG Therapeutics Inc
NASDAQ:TGTX
Average EV/EBIT: 49.5
47.6
123%
0.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 400.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.3
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.1
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
13%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
221.7
N/A N/A
AU
CSL Ltd
ASX:CSL
16.6
11%
1.5
NL
argenx SE
XBRU:ARGX
63.7
N/A N/A